{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T02:15:44Z","timestamp":1789438544437,"version":"build-2803163510"},"reference-count":38,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2007,11,1]],"date-time":"2007-11-01T00:00:00Z","timestamp":1193875200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2007,11,1]],"date-time":"2007-11-01T00:00:00Z","timestamp":1193875200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2013,8,22]],"date-time":"2013-08-22T00:00:00Z","timestamp":1377129600000},"content-version":"vor","delay-in-days":2121,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Virology"],"published-print":{"date-parts":[[2007,11]]},"DOI":"10.1016\/j.virol.2007.06.013","type":"journal-article","created":{"date-parts":[[2007,7,17]],"date-time":"2007-07-17T07:18:31Z","timestamp":1184656711000},"page":"172-181","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":44,"title":["Genetic characteristics of HIV-1 subtype C envelopes inducing cross-neutralizing antibodies"],"prefix":"10.1016","volume":"368","author":[{"given":"Cecilia","family":"Rademeyer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Penny L.","family":"Moore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natasha","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darren P.","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isaac A.","family":"Choge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elin S.","family":"Gray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haynes W.","family":"Sheppard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clive","family":"Gray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lynn","family":"Morris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolyn","family":"Williamson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.virol.2007.06.013_bib1","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1038\/72309","article-title":"Human neutralizing monoclonal antibodies of the IgG1 subtype protect against mucosal simian\u2013human immunodeficiency virus infection","volume":"6","author":"Baba","year":"2000","journal-title":"Nat. Med."},{"issue":"23","key":"10.1016\/j.virol.2007.06.013_bib2","doi-asserted-by":"crossref","first-page":"13232","DOI":"10.1128\/JVI.78.23.13232-13252.2004","article-title":"Comprehensive cross-clade neutralization analysis of a panel of anti-human immunodeficiency virus type 1 monoclonal antibodies","volume":"78","author":"Binley","year":"2004","journal-title":"J. Virol."},{"issue":"5","key":"10.1016\/j.virol.2007.06.013_bib3","doi-asserted-by":"crossref","first-page":"2233","DOI":"10.1128\/jvi.76.5.2233-2244.2002","article-title":"Regional clustering of shared neutralization determinants on primary isolates of clade C human immunodeficiency virus type 1 from South Africa","volume":"76","author":"Bures","year":"2002","journal-title":"J. Virol."},{"issue":"12","key":"10.1016\/j.virol.2007.06.013_bib4","doi-asserted-by":"crossref","first-page":"9808","DOI":"10.1128\/jvi.71.12.9808-9812.1997","article-title":"Replication and neutralization of human immunodeficiency virus type 1 lacking the V1 and V2 variable loops of the gp120 envelope glycoprotein","volume":"71","author":"Cao","year":"1997","journal-title":"J. Virol."},{"issue":"7","key":"10.1016\/j.virol.2007.06.013_bib5","doi-asserted-by":"crossref","first-page":"5294","DOI":"10.1128\/JVI.73.7.5294-5300.1999","article-title":"Selection for neutralization resistance of the simian\/human immunodeficiency virus SHIVSF33A variant in vivo by virtue of sequence changes in the extracellular envelope glycoprotein that modify N-linked glycosylation","volume":"73","author":"Cheng-Mayer","year":"1999","journal-title":"J. Virol."},{"issue":"5666","key":"10.1016\/j.virol.2007.06.013_bib6","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1126\/science.1093137","article-title":"Envelope-constrained neutralization-sensitive HIV-1 after heterosexual transmission","volume":"303","author":"Derdeyn","year":"2004","journal-title":"Science"},{"issue":"7","key":"10.1016\/j.virol.2007.06.013_bib7","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/S1473-3099(04)01056-4","article-title":"Prospects for an AIDS vaccine: three big questions, no easy answers","volume":"4","author":"Garber","year":"2004","journal-title":"Lancet Infect. Dis."},{"issue":"4","key":"10.1016\/j.virol.2007.06.013_bib8","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1089\/aid.2005.21.285","article-title":"Viral dynamics and CD4+ T cell counts in subtype C human immunodeficiency virus type 1-infected individuals from southern Africa","volume":"21","author":"Gray","year":"2005","journal-title":"AIDS Res. Hum. Retroviruses"},{"issue":"7","key":"10.1016\/j.virol.2007.06.013_bib9","doi-asserted-by":"crossref","first-page":"e255","DOI":"10.1371\/journal.pmed.0030255","article-title":"Insensitivity of paediatric HIV-1 subtype C viruses to broadly neutralising monoclonal antibodies raised against subtype B","volume":"3","author":"Gray","year":"2006","journal-title":"PLoS Med."},{"issue":"12","key":"10.1016\/j.virol.2007.06.013_bib10","doi-asserted-by":"crossref","first-page":"6187","DOI":"10.1128\/JVI.00239-07","article-title":"Neutralizing antibody responses in acute human immunodeficiency virus type 1 subtype C infection","volume":"81","author":"Gray","year":"2007","journal-title":"J. Virol."},{"issue":"5","key":"10.1016\/j.virol.2007.06.013_bib11","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1080\/10635150390235520","article-title":"A simple, fast, and accurate algorithm to estimate large phylogenies by maximum likelihood","volume":"52","author":"Guindon","year":"2003","journal-title":"Syst. Biol."},{"key":"10.1016\/j.virol.2007.06.013_bib12","first-page":"95","article-title":"BioEdit: a user-friendly biological sequence alignment editor and analysis program for Windows 95\/08\/NT","volume":"41","author":"Hall","year":"1999","journal-title":"Nucleic Acids Symp. Ser."},{"issue":"16","key":"10.1016\/j.virol.2007.06.013_bib13","doi-asserted-by":"crossref","first-page":"7470","DOI":"10.1128\/JVI.75.16.7470-7480.2001","article-title":"Postnatal passive immunization of neonatal macaques with a triple combination of human monoclonal antibodies against oral simian\u2013human immunodeficiency virus challenge","volume":"75","author":"Hofmann-Lehmann","year":"2001","journal-title":"J. Virol."},{"issue":"3","key":"10.1016\/j.virol.2007.06.013_bib14","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1080\/10618600.1996.10474713","article-title":"R: a language for data analysis and graphics","volume":"5","author":"Ihaka","year":"1996","journal-title":"J. Comput. Graph. Stat."},{"issue":"1","key":"10.1016\/j.virol.2007.06.013_bib15","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1128\/jvi.70.1.445-458.1996","volume":"70","author":"Kostrikis","year":"1996","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2007.06.013_bib16","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1146\/annurev.immunol.20.081501.094854","article-title":"Prospects for vaccine protection against HIV-1 infection and AIDS","volume":"20","author":"Letvin","year":"2002","journal-title":"Annu. Rev. Immunol."},{"issue":"16","key":"10.1016\/j.virol.2007.06.013_bib17","doi-asserted-by":"crossref","first-page":"10200","DOI":"10.1128\/JVI.79.16.10108-10125.2005","article-title":"Human immunodeficiency virus type 1 env clones from acute and early subtype B infections for standardized assessments of vaccine-elicited neutralizing antibodies","volume":"79","author":"Li","year":"2005","journal-title":"J. Virol."},{"issue":"11","key":"10.1016\/j.virol.2007.06.013_bib18","doi-asserted-by":"crossref","first-page":"5211","DOI":"10.1128\/JVI.00201-06","article-title":"Evidence for potent autologous neutralizing antibody titers and compact envelopes in early infection with subtype C human immunodeficiency virus type 1","volume":"80","author":"Li","year":"2006","journal-title":"J. Virol."},{"issue":"23","key":"10.1016\/j.virol.2007.06.013_bib19","doi-asserted-by":"crossref","first-page":"11776","DOI":"10.1128\/JVI.01730-06","article-title":"Genetic and neutralization properties of subtype C human immunodeficiency virus type 1 molecular env clones from acute and early heterosexually acquired infections in Southern Africa","volume":"80","author":"Li","year":"2006","journal-title":"J. Virol."},{"issue":"15","key":"10.1016\/j.virol.2007.06.013_bib20","doi-asserted-by":"crossref","first-page":"6769","DOI":"10.1128\/JVI.74.15.6769-6776.2000","article-title":"V2 loop glycosylation of the human immunodeficiency virus type 1 SF162 envelope facilitates interaction of this protein with CD4 and CCR5 receptors and protects the virus from neutralization by anti-V3 loop and anti-CD4 binding site antibodies","volume":"74","author":"Ly","year":"2000","journal-title":"J. Virol."},{"issue":"3","key":"10.1016\/j.virol.2007.06.013_bib21","doi-asserted-by":"crossref","first-page":"209","DOI":"10.2174\/1566524033479799","article-title":"Defining the protective antibody response for HIV-1","volume":"3","author":"Mascola","year":"2003","journal-title":"Curr. Mol. Med."},{"issue":"5","key":"10.1016\/j.virol.2007.06.013_bib22","doi-asserted-by":"crossref","first-page":"4009","DOI":"10.1128\/JVI.73.5.4009-4018.1999","article-title":"Protection of Macaques against pathogenic simian\/human immunodeficiency virus 89.6\u00a0PD by passive transfer of neutralizing antibodies","volume":"73","author":"Mascola","year":"1999","journal-title":"J. Virol."},{"issue":"2","key":"10.1016\/j.virol.2007.06.013_bib23","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1038\/72318","article-title":"Protection of macaques against vaginal transmission of a pathogenic HIV-1\/SIV chimeric virus by passive infusion of neutralizing antibodies","volume":"6","author":"Mascola","year":"2000","journal-title":"Nat. Med."},{"issue":"1","key":"10.1016\/j.virol.2007.06.013_bib24","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1128\/jvi.70.1.427-444.1996","article-title":"Inter- and intraclade neutralization of human immunodeficiency virus type 1: genetic clades do not correspond to neutralization serotypes but partially correspond to gp120 antigenic serotypes","volume":"70","author":"Moore","year":"1996","journal-title":"J. Virol."},{"issue":"9","key":"10.1016\/j.virol.2007.06.013_bib25","doi-asserted-by":"crossref","first-page":"6235","DOI":"10.1128\/jvi.70.9.6235-6243.1996","article-title":"Multivariate analysis of human immunodeficiency virus type 1 neutralization data","volume":"70","author":"Nyambi","year":"1996","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2007.06.013_bib26","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1146\/annurev.immunol.24.021605.090557","article-title":"GP120: target for neutralizing HIV-1 antibodies","volume":"24","author":"Pantophlet","year":"2006","journal-title":"Annu. Rev. Immunol."},{"issue":"17","key":"10.1016\/j.virol.2007.06.013_bib27","doi-asserted-by":"crossref","first-page":"8340","DOI":"10.1128\/JVI.75.17.8340-8347.2001","article-title":"Antibody protects macaques against vaginal challenge with a pathogenic R5 simian\/human immunodeficiency virus at serum levels giving complete neutralization in vitro","volume":"75","author":"Parren","year":"2001","journal-title":"J. Virol."},{"issue":"10","key":"10.1016\/j.virol.2007.06.013_bib28","doi-asserted-by":"crossref","first-page":"5205","DOI":"10.1128\/JVI.78.10.5205-5215.2004","article-title":"The V1\/V2 domain of gp120 is a global regulator of the sensitivity of primary human immunodeficiency virus type 1 isolates to neutralization by antibodies commonly induced upon infection","volume":"78","author":"Pinter","year":"2004","journal-title":"J. Virol."},{"issue":"7","key":"10.1016\/j.virol.2007.06.013_bib29","doi-asserted-by":"crossref","first-page":"4144","DOI":"10.1073\/pnas.0630530100","article-title":"Rapid evolution of the neutralizing antibody response to HIV type 1 infection","volume":"100","author":"Richman","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"19","key":"10.1016\/j.virol.2007.06.013_bib30","doi-asserted-by":"crossref","first-page":"9586","DOI":"10.1128\/JVI.00141-06","article-title":"Human immunodeficiency virus type 1 V1\u2013V2 envelope loop sequences expand and add glycosylation sites over the course of infection, and these modifications affect antibody neutralization sensitivity","volume":"80","author":"Sagar","year":"2006","journal-title":"J. Virol."},{"issue":"4","key":"10.1016\/j.virol.2007.06.013_bib31","doi-asserted-by":"crossref","first-page":"2310","DOI":"10.1128\/JVI.77.4.2310-2320.2003","article-title":"Changes in the immunogenic properties of soluble gp140 human immunodeficiency virus envelope constructs upon partial deletion of the second hypervariable region","volume":"77","author":"Srivastava","year":"2003","journal-title":"J. Virol."},{"issue":"6","key":"10.1016\/j.virol.2007.06.013_bib32","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1038\/nm1244","article-title":"Delay of HIV-1 rebound after cessation of antiretroviral therapy through passive transfer of human neutralizing antibodies","volume":"11","author":"Trkola","year":"2005","journal-title":"Nat. Med."},{"key":"10.1016\/j.virol.2007.06.013_bib33","unstructured":"UNAIDS\/WHO, 2006. UNAIDS\/WHO AIDS Epidemic Update. http:\/\/www.unaids.org\/en\/HIV_data\/epi2006."},{"issue":"3","key":"10.1016\/j.virol.2007.06.013_bib34","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1038\/nm833","article-title":"Prevention of virus transmission to macaque monkeys by a vaginally applied monoclonal antibody to HIV-1 gp120","volume":"9","author":"Veazey","year":"2003","journal-title":"Nat. Med."},{"issue":"11","key":"10.1016\/j.virol.2007.06.013_bib35","doi-asserted-by":"crossref","first-page":"7827","DOI":"10.1128\/jvi.70.11.7827-7832.1996","article-title":"Neutralization serotypes of human immunodeficiency virus type 1 field isolates are not predicted by genetic subtype. The WHO Network for HIV Isolation and Characterization","volume":"70","author":"Weber","year":"1996","journal-title":"J. Virol."},{"issue":"6929","key":"10.1016\/j.virol.2007.06.013_bib36","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/nature01470","article-title":"Antibody neutralization and escape by HIV-1","volume":"422","author":"Wei","year":"2003","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.virol.2007.06.013_bib37","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1089\/088922203762688649","article-title":"Characterization and selection of HIV-1 subtype C isolates for use in vaccine development","volume":"19","author":"Williamson","year":"2003","journal-title":"AIDS Res. Hum. Retroviruses"},{"issue":"2","key":"10.1016\/j.virol.2007.06.013_bib38","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1128\/JVI.79.2.1252-1261.2005","article-title":"Anti-human immunodeficiency virus type 1 (HIV-1) antibodies 2F5 and 4E10 require surprisingly few crucial residues in the membrane-proximal external region of glycoprotein gp41 to neutralize HIV-1","volume":"79","author":"Zwick","year":"2005","journal-title":"J. Virol."}],"container-title":["Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0042682207004242?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0042682207004242?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T23:49:02Z","timestamp":1758584942000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0042682207004242"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,11]]},"references-count":38,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2007,11]]}},"alternative-id":["S0042682207004242"],"URL":"https:\/\/doi.org\/10.1016\/j.virol.2007.06.013","relation":{},"ISSN":["0042-6822"],"issn-type":[{"value":"0042-6822","type":"print"}],"subject":[],"published":{"date-parts":[[2007,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Genetic characteristics of HIV-1 subtype C envelopes inducing cross-neutralizing antibodies","name":"articletitle","label":"Article Title"},{"value":"Virology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.virol.2007.06.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2007 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}